Global Bioresorbable Bone-graft Substitute Market Growth (Status and Outlook) 2024-2030

Global Bioresorbable Bone-graft Substitute Market Growth (Status and Outlook) 2024-2030

Bioresorbable bone-graft substitute is a medical material designed to support bone healing and regeneration while gradually being absorbed and replaced by natural bone over time. These substitutes are used in orthopedic and dental surgeries to repair bone defects or enhance bone regeneration.

The global Bioresorbable Bone-graft Substitute market size is projected to grow from US$ 730 million in 2024 to US$ 1504 million in 2030; it is expected to grow at a CAGR of 12.8% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Bioresorbable Bone-graft Substitute Industry Forecast” looks at past sales and reviews total world Bioresorbable Bone-graft Substitute sales in 2022, providing a comprehensive analysis by region and market sector of projected Bioresorbable Bone-graft Substitute sales for 2023 through 2029. With Bioresorbable Bone-graft Substitute sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioresorbable Bone-graft Substitute industry.

This Insight Report provides a comprehensive analysis of the global Bioresorbable Bone-graft Substitute landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bioresorbable Bone-graft Substitute portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioresorbable Bone-graft Substitute market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioresorbable Bone-graft Substitute and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioresorbable Bone-graft Substitute.

United States market for Bioresorbable Bone-graft Substitute is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Bioresorbable Bone-graft Substitute is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Bioresorbable Bone-graft Substitute is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Bioresorbable Bone-graft Substitute players cover Kuraray, Zimmer Biomet, Leaderbiomedical, Absorbable Artificial Bone, Swallow Dental, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioresorbable Bone-graft Substitute market by product type, application, key players and key regions and countries.

Segmentation by Type:
Calcium Phosphate-based Materials
Collagen-based Materials

Segmentation by Application:
Orthopedic Surgery
Dental Surgery

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Calcium Phosphate-based Materials
Collagen-based Materials

Segmentation by Application:
Orthopedic Surgery
Dental Surgery

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Kuraray
Zimmer Biomet
Leaderbiomedical
Absorbable Artificial Bone
Swallow Dental
Tracxn
Baxter International Inc.
Biocomposites
DePuy Synthes (Johnson & Johnson)
Geistlich Pharma
Ligamed Biomaterials Co
Medtronic
PuraGraft
Stryker Corporation
Teknimed

Please note: The report will take approximately 2 business days to prepare and deliver.